Predict your next investment

Corporation
integrium.com

See what CB Insights has to offer

Investments

1

Portfolio Exits

1

About Integrium Clinical Research

Integrium is a full-service Clinical Proof of Concept (PoC) Firm focused within the therapeutic areas of Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Regenerative, and Orphan Disease. Although we have the scientific, medical, operational, and regulatory expertise to cover all stages of clinical development (Phase I-IV), we are Experts in the Strategy, Design and Execution of Clinical PoC Trials.

Integrium Clinical Research Headquarter Location

100 E. Hanover Avenue Suite 401

Cedar Knolls, New Jersey, 7927,

United States

877-332-1572

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Integrium Clinical Research

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Integrium Clinical Research in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Integrium Clinical Research Investments

1 Investments

Integrium Clinical Research has made 1 investments. Their latest investment was in Oncolix as part of their Series A on January 1, 2015.

CBI Logo

Integrium Clinical Research Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/22/2015

Series A

Oncolix

$4.51M

Yes

2

Date

1/22/2015

Round

Series A

Company

Oncolix

Amount

$4.51M

New?

Yes

Co-Investors

Sources

2

Integrium Clinical Research Portfolio Exits

1 Portfolio Exit

Integrium Clinical Research has 1 portfolio exit. Their latest portfolio exit was Oncolix on August 07, 2017.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/7/2017

Reverse Merger

1

Date

8/7/2017

Exit

Reverse Merger

Companies

Valuation

Acquirer

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.